What is the Olympus Corporation stock price forecast?

Olympus Corporation is currently trading at ¥1,612. View real-time AI analysis on Alpha Lenz.

What is Olympus Corporation insider trading activity?

View the latest insider trading data for Olympus Corporation on Alpha Lenz.

What is Olympus Corporation's P/E ratio?

Olympus Corporation's P/E ratio is 15.7.

Olympus Corporation

JPX · 7733

¥1,612-50(-3.01%)Market closed

Ask about Olympus Corporation's future dividend policy...

Alpha Chat Insight

“Olympus Corporation trades at a P/E of 15.7 (fair value) with strong ROE of 15.6%.”

Ask for details →

Company Overview

Olympus Corporation is a prominent entity in the medical technology and precision instruments industry. Founded in 1919 and headquartered in Tokyo, Japan, it's renowned for developing, manufacturing, and selling medical equipment, scientific devices, and cameras. Olympus plays a pivotal role in the healthcare sector, particularly through its endoscopes and surgical instruments, which are utilized in various medical procedures worldwide, enhancing the capabilities of medical professionals. The company is also a key player in the field of microscopy and imaging systems used for research in life sciences and industrial applications. In the financial markets, Olympus Corporation is recognized for its innovative contributions to medical technology, impacting global healthcare and research industries by consistently pushing the boundaries of precision and quality in its products.

CEOMr. Robert John White

Websitehttps://www.olympus-global.com

SectorHealthcare

IndustryMedical Devices

Employees29,297

Company Statistics

FY 2025

Profile

¥1,844,667,054,412Market Cap

¥997,332,000,000Revenue

0.00Shares Out

29,297Employees

Margins

68.55%Gross

23.30%EBITDA

16.24%Operating

15.95%Pre-Tax

11.82%Net

Valuation

15.65P/E

2.45P/B

1.85EV/Sales

7.84EV/EBITDA

14.73P/FCF

Growth (CAGR)

9.96%Rev 3Yr

5.72%Rev 5Yr

3.84%Op Inc 3Yr

12.05%Op Inc 5Yr

0.54%Net Inc 3Yr

17.94%Net Inc 5Yr

Returns

7.94%ROA

15.62%ROE

11.18%ROIC

Financial Health

¥252,532,000,000Cash & Cash Equivalents

¥428,561,000,000Net Debt

90.60%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Olympus Corporation trades at a P/E of 15.7 (fair value) with strong ROE of 15.6%.”

Ask for details →

Frequently Asked Questions

Olympus Corporation (ticker: 7733) is a company listed on JPX in the Healthcare sector (Medical Devices). It has approximately 29,297 employees. Market cap is $1.8T.

The current price is 1,612 with a P/E ratio of 15.65x and P/B of 2.45x.

ROE is 15.62% and operating margin is 16.24%. Annual revenue is $997.3B.